Home › Studies › PRJNA1300320
PRJNA1300320 SRP605845

Gut microbiome, SARS-CoV-2 vaccine response in PLWH, Sweden

Association of metabolic pathways and antibiotic resistance gene dynamics with SARS-CoV-2 vaccine efficacy in PLWH

114 gut metagenome samples from Sweden, from people living with HIV and healthy controls (89 adults, 25 elderly), examining links between microbiome metabolic pathways, resistome, and SARS-CoV-2 vaccine immunogenicity; cross-sectional design. machine-written summary

114 samples · 114 runs · SE · Adult · 2026 · 9.16 Gbp / sample

Sources
✓Sequence archive 684–Abstract / description–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive684 sample values (age, collection date, country, health condition, health condition detail, sex)
– Abstract / descriptionno abstract or project description
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Vaccination as the study intervention design observational_with_procedure · population transplant_or_immunocompromised · SARS-CoV-2 vaccination in PLWH and healthy controls

“SARS-CoV-2 vaccine efficacy in PLWH” — study.title (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 country
Age
adult89
elderly25
Condition
healthy_control75
other_infection39
Sex
female58
male56
Country
SE114
Body site
primary114
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 1 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 74 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 39 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 9.16 Gbp per sample0130Gbp
Community composition
Prevotella 11.7%Bacteroides 8.3%Phocaeicola 7.4%Faecalibacterium 5.1%Alistipes 4.2%Roseburia 2.8%Vescimonas 2.5%Blautia_A 1.7%Parabacteroides 1.5%Hominicoprocola 1.4%Bifidobacterium 1.4%Gemmiger 1.4%not assigned to a genus 4.1%other genera 46.6%

Genera, mean relative abundance over 109 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category114 100%
country114 100%114
health_condition114 100%114
subject_id0 0%
age_at_collection_days114 100%114
collection_date114 100%114
health_condition_detail114 100%114
sex114 100%114
Details
Archive description

The study highlights a link between microbiome dysbiosis and the immune response to SARS-CoV-2 vaccination, suggesting an interplay between the gut microbiome and immune status in people living with HIV. We investigated how vaccine immunogenicity correlates with the differential abundance of microbiota-driven metabolic pathways and alterations in resistome patterns in both PLWH and healthy controls.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult and elderly by sonnet_x2 with confidence 0.65. Assay shotgun_dna.

  • host run.scientific_name · “Homo sapiens”
  • body site study.description · “gut microbiome and immune status”
  • life stage sample.attr.age · “33 (n=83/114)”
  • life stage sample.attr.age · “64 (n=31/114)”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN50328777age_at_collection_days24090.0R10.85sample.attr.age66
SAMN50328777collection_date2021R10.90biosample.attribute:collection_date2021
SAMN50328777countrySER10.90sample.attr.geo_loc_nameSweden
SAMN50328777health_conditionhealthy_controlR10.85biosample.attribute:isolateisolate: Healthy Control
SAMN50328777health_condition_detailHealthy ControlR10.85biosample.attribute:isolateisolate: Healthy Control
SAMN50328777sexfemaleR10.90sample.attr.sexfemale
Sequencing

114 runs over 114 samples · mean 9.15 Gbp per run (median 9.16 Gbp, total 1,042.98 Gbp; 114 runs with a base count) · layout PAIRED 114 · platform ILLUMINA 114 · models Illumina NovaSeq 6000 (114) · 96% of runs with a Sandpiper profile · first public 2026-01-02 – 2026-01-20

Authors (0)

No author record.

Downloads

PRJNA1300320.csv.gz (4.1 KB) · parquet (74.5 KB) — all 114 samples, every field with route and confidence · PRJNA1300320_determinations.csv.gz (4.6 KB) — 684 evidence rows

Samples (114 · every field this project has values for · hover a cell for its source)
Loading the sample table…